JP2014088432A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014088432A5 JP2014088432A5 JP2014007144A JP2014007144A JP2014088432A5 JP 2014088432 A5 JP2014088432 A5 JP 2014088432A5 JP 2014007144 A JP2014007144 A JP 2014007144A JP 2014007144 A JP2014007144 A JP 2014007144A JP 2014088432 A5 JP2014088432 A5 JP 2014088432A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- genetically modified
- stem cells
- use according
- promoter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 claims 39
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 claims 39
- 210000000130 stem cell Anatomy 0.000 claims 39
- 239000003623 enhancer Substances 0.000 claims 15
- 102000004169 proteins and genes Human genes 0.000 claims 10
- 108090000623 proteins and genes Proteins 0.000 claims 10
- 230000004663 cell proliferation Effects 0.000 claims 9
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 8
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 8
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 8
- 210000002889 endothelial cell Anatomy 0.000 claims 8
- 208000014674 injury Diseases 0.000 claims 7
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 6
- 230000000735 allogeneic effect Effects 0.000 claims 6
- 230000008733 trauma Effects 0.000 claims 6
- 230000037396 body weight Effects 0.000 claims 5
- 210000001185 bone marrow Anatomy 0.000 claims 5
- 210000004027 cell Anatomy 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 210000003038 endothelium Anatomy 0.000 claims 5
- 238000004519 manufacturing process Methods 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 5
- 150000007523 nucleic acids Chemical class 0.000 claims 5
- 238000001356 surgical procedure Methods 0.000 claims 5
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims 4
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims 4
- 206010012601 diabetes mellitus Diseases 0.000 claims 4
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 3
- 230000033115 angiogenesis Effects 0.000 claims 3
- 208000010643 digestive system disease Diseases 0.000 claims 3
- 208000018685 gastrointestinal system disease Diseases 0.000 claims 3
- 210000003205 muscle Anatomy 0.000 claims 3
- 210000000663 muscle cell Anatomy 0.000 claims 3
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- 230000001154 acute effect Effects 0.000 claims 2
- 230000004089 microcirculation Effects 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 230000029663 wound healing Effects 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 102000001039 Dystrophin Human genes 0.000 claims 1
- 108010069091 Dystrophin Proteins 0.000 claims 1
- 101001023030 Toxoplasma gondii Myosin-D Proteins 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 238000012084 abdominal surgery Methods 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- 230000035606 childbirth Effects 0.000 claims 1
- 206010009887 colitis Diseases 0.000 claims 1
- 238000002316 cosmetic surgery Methods 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 238000002350 laparotomy Methods 0.000 claims 1
- 201000006938 muscular dystrophy Diseases 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93162207P | 2007-05-24 | 2007-05-24 | |
| US60/931,622 | 2007-05-24 | ||
| US305007P | 2007-11-14 | 2007-11-14 | |
| US61/003,050 | 2007-11-14 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509362A Division JP2010528008A (ja) | 2007-05-24 | 2008-05-20 | Ｃｄ３４幹細胞に関連した方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014088432A JP2014088432A (ja) | 2014-05-15 |
| JP2014088432A5 true JP2014088432A5 (enExample) | 2014-10-16 |
Family
ID=40093981
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509362A Pending JP2010528008A (ja) | 2007-05-24 | 2008-05-20 | Ｃｄ３４幹細胞に関連した方法および組成物 |
| JP2014007144A Pending JP2014088432A (ja) | 2007-05-24 | 2014-01-17 | Ｃｄ３４幹細胞に関連した方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010509362A Pending JP2010528008A (ja) | 2007-05-24 | 2008-05-20 | Ｃｄ３４幹細胞に関連した方法および組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (5) | US7998472B2 (enExample) |
| EP (4) | EP2162534B1 (enExample) |
| JP (2) | JP2010528008A (enExample) |
| CN (2) | CN101778934B (enExample) |
| AU (1) | AU2008260651B2 (enExample) |
| BR (1) | BRPI0811906A2 (enExample) |
| CA (1) | CA2688032C (enExample) |
| DK (1) | DK2223696T3 (enExample) |
| ES (3) | ES2430071T3 (enExample) |
| PL (1) | PL2162534T3 (enExample) |
| WO (1) | WO2008150368A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100291042A1 (en) | 2007-05-03 | 2010-11-18 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
| US8574567B2 (en) | 2007-05-03 | 2013-11-05 | The Brigham And Women's Hospital, Inc. | Multipotent stem cells and uses thereof |
| US12180549B2 (en) | 2007-07-23 | 2024-12-31 | The Chinese University Of Hong Kong | Diagnosing fetal chromosomal aneuploidy using genomic sequencing |
| HUE061020T2 (hu) | 2007-07-23 | 2023-05-28 | Univ Hong Kong Chinese | Nukleinsav-szekvencia kiegyensúlyozatlanságának meghatározására |
| EP2303293A1 (en) * | 2008-05-27 | 2011-04-06 | Pluristem Ltd. | Methods of treating inflammatory colon diseases |
| KR20120088542A (ko) | 2009-04-13 | 2012-08-08 | 아프세스 게엠베하 & 씨오. 카게 | 종양 치료를 위한 조작된 중간엽 줄기세포 및 이를 사용하는 방법 |
| US20110027239A1 (en) * | 2009-07-29 | 2011-02-03 | Tissue Genesis, Inc. | Adipose-derived stromal cells (asc) as delivery tool for treatment of cancer |
| US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| JP5579270B2 (ja) * | 2010-08-06 | 2014-08-27 | 国立大学法人大阪大学 | 膵島と脂肪組織由来幹細胞を利用した膵島移植 |
| US8834928B1 (en) | 2011-05-16 | 2014-09-16 | Musculoskeletal Transplant Foundation | Tissue-derived tissugenic implants, and methods of fabricating and using same |
| RS57886B1 (sr) | 2011-11-30 | 2019-01-31 | Astellas Inst For Regenerative Medicine | Mezenhimalne stromalne ćelije i primene vezane za njih |
| US8961956B2 (en) | 2011-11-30 | 2015-02-24 | Ocata Therapeutics, Inc. | Mesenchymal stromal cells and uses related thereto |
| US20130171115A1 (en) * | 2011-12-30 | 2013-07-04 | Gang Li | Cell-mediated gene therapy for cancer using mesenchymal stem cells expressing a suicide gene |
| CN104160027B (zh) * | 2012-02-01 | 2016-06-22 | 浦项工科大学校产学协力团 | 同时表达十二聚体trail及hsv-tk自杀基因的载体及利用其的抗癌干细胞治疗剂 |
| US9892230B2 (en) | 2012-03-08 | 2018-02-13 | The Chinese University Of Hong Kong | Size-based analysis of fetal or tumor DNA fraction in plasma |
| CA2876499C (en) | 2012-07-12 | 2021-10-26 | Imstem Biotechnology, Inc. | Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof |
| EP3027235A1 (en) | 2013-07-30 | 2016-06-08 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| WO2016026854A2 (en) * | 2014-08-18 | 2016-02-25 | Apceth Gmbh & Co. Kg | Genetically modified mesenchymal stem cells expressing an immune response-stimulating cytokine to attract and/or activate immune cells |
| US10364467B2 (en) | 2015-01-13 | 2019-07-30 | The Chinese University Of Hong Kong | Using size and number aberrations in plasma DNA for detecting cancer |
| CN104622903B (zh) * | 2015-01-20 | 2018-10-09 | 奥思达干细胞有限公司 | 抗恶性黑色素瘤的干细胞制剂及其制备方法 |
| EP3297694A1 (en) | 2015-05-21 | 2018-03-28 | Musculoskeletal Transplant Foundation | Modified demineralized cortical bone fibers |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US11052175B2 (en) | 2015-08-19 | 2021-07-06 | Musculoskeletal Transplant Foundation | Cartilage-derived implants and methods of making and using same |
| WO2017167959A1 (en) | 2016-04-01 | 2017-10-05 | Apceth Gmbh & Co. Kg | Mesenchymal stem cells to enhance anti-tumor activity of immunotherapy |
| AU2018225436B2 (en) * | 2017-02-24 | 2023-07-13 | The Board Of Regents Of The University Of Texas System | Compositions and methods relating to myomixer-promoted muscle cell fusion |
| EP3366303B1 (en) * | 2017-02-28 | 2020-06-24 | Martin-Luther-Universität Halle-Wittenberg | Enhancing the targeted in vivo delivery of cellular therapies |
| JP2020516654A (ja) | 2017-04-13 | 2020-06-11 | センティ バイオサイエンシズ インコーポレイテッド | 組み合わせがん免疫療法 |
| EP3807304A1 (en) | 2018-06-15 | 2021-04-21 | Children's Hospital Medical Center | Polypeptides, nucleic acid molecules, compositions, and related methods |
| US11419898B2 (en) | 2018-10-17 | 2022-08-23 | Senti Biosciences, Inc. | Combinatorial cancer immunotherapy |
| TW202035685A (zh) | 2018-10-17 | 2020-10-01 | 美商聖堤生物科技股份有限公司 | 組合癌症免疫療法 |
| CN120678804A (zh) * | 2025-08-07 | 2025-09-23 | 黄永茂 | 调理人体经络生物电的氯化氢组分液及其应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7514074B2 (en) * | 1997-07-14 | 2009-04-07 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
| US20010038834A1 (en) | 1998-01-26 | 2001-11-08 | Gary Balian | Bone cancer therapy |
| US20030100107A1 (en) * | 1998-05-29 | 2003-05-29 | Thomas Jefferson University | Compositions and methods for generating differentiated human cells |
| DE19833476B4 (de) * | 1998-07-24 | 2005-08-25 | Huss, Ralf, Dr. | Genetisch modifizierte CD34-Negative, adhärent wachsende hämatopoetische Stammzellen und deren Verwendung in der Gentherapie |
| US20030082155A1 (en) * | 1999-12-06 | 2003-05-01 | Habener Joel F. | Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| JP2003523323A (ja) * | 1999-12-06 | 2003-08-05 | ザ ジェネラル ホスピタル コーポレーション | 膵臓幹細胞および移植におけるその使用 |
| IL156132A0 (en) * | 2000-11-27 | 2003-12-23 | Yissum Res Dev Co | Transfection of human embryonic stem cells |
| US7268212B2 (en) * | 2001-06-14 | 2007-09-11 | Takeda Pharmaceutical Company Limited | Ligand of G protein-coupled receptor protein and DNA thereof |
| EP1430115A1 (en) | 2001-07-27 | 2004-06-23 | Arhus Amt | Immortilized stem cells |
| WO2003025167A2 (en) | 2001-09-20 | 2003-03-27 | Centre For Translational Research In Cancer | Cultured stromal cells and uses thereof |
| WO2003087333A2 (en) * | 2002-04-12 | 2003-10-23 | Celgene Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| JP2005532810A (ja) * | 2002-07-16 | 2005-11-04 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム | 組織修復および組織形成のために間葉性幹細胞を移植する方法 |
| CA2505251A1 (en) * | 2002-11-05 | 2004-05-27 | Brigham And Women's Hospital, Inc. | Mesenchymal stem cells and methods of use thereof |
| US20060216277A1 (en) | 2003-09-15 | 2006-09-28 | Ramot At Tel Aviv University Ltd. | Insulin-producing bone marrow derived cells and methods of generating and using same |
| JP2007520462A (ja) * | 2003-12-19 | 2007-07-26 | バイアセル インコーポレーティッド | ヒト臍帯血由来多能性細胞の疾患の処置のための使用方法 |
| EP2298863B1 (en) * | 2004-03-22 | 2015-07-22 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| EP1729788B1 (en) * | 2004-03-30 | 2009-11-25 | Boston Scientific Limited | Restenosis therapy using mesenchymal stem cells |
| JP2006345726A (ja) | 2005-06-14 | 2006-12-28 | Hamamatsu Univ School Of Medicine | 脳腫瘍治療用発現ベクター |
| KR101022401B1 (ko) * | 2005-09-29 | 2011-03-15 | 아주대학교산학협력단 | 자살유전자를 발현하는 중간엽 줄기세포를 포함하는 암치료용 조성물 |
-
2008
- 2008-05-20 AU AU2008260651A patent/AU2008260651B2/en not_active Ceased
- 2008-05-20 CN CN2008801001004A patent/CN101778934B/zh not_active Expired - Fee Related
- 2008-05-20 CA CA2688032A patent/CA2688032C/en not_active Expired - Fee Related
- 2008-05-20 EP EP08754569.5A patent/EP2162534B1/en not_active Not-in-force
- 2008-05-20 ES ES10163667T patent/ES2430071T3/es active Active
- 2008-05-20 ES ES08754569.5T patent/ES2507507T3/es active Active
- 2008-05-20 PL PL08754569T patent/PL2162534T3/pl unknown
- 2008-05-20 BR BRPI0811906-6A2A patent/BRPI0811906A2/pt not_active IP Right Cessation
- 2008-05-20 DK DK10163667.8T patent/DK2223696T3/da active
- 2008-05-20 CN CN201310125890.4A patent/CN103263439B/zh not_active Expired - Fee Related
- 2008-05-20 EP EP10163667.8A patent/EP2223696B1/en not_active Not-in-force
- 2008-05-20 EP EP10163663A patent/EP2229948B1/en not_active Not-in-force
- 2008-05-20 EP EP14172302.3A patent/EP2851422A3/en not_active Withdrawn
- 2008-05-20 US US12/154,059 patent/US7998472B2/en not_active Expired - Fee Related
- 2008-05-20 JP JP2010509362A patent/JP2010528008A/ja active Pending
- 2008-05-20 ES ES10163663T patent/ES2401608T3/es active Active
- 2008-05-20 WO PCT/US2008/006434 patent/WO2008150368A1/en not_active Ceased
-
2011
- 2011-07-08 US US13/179,374 patent/US20110268714A1/en not_active Abandoned
-
2014
- 2014-01-17 JP JP2014007144A patent/JP2014088432A/ja active Pending
-
2015
- 2015-05-08 US US14/707,872 patent/US20150238541A1/en not_active Abandoned
- 2015-05-08 US US14/707,654 patent/US20150238526A1/en not_active Abandoned
- 2015-05-08 US US14/707,739 patent/US20160136207A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heiman et al. | Toll-like receptors in central nervous system injury and disease: a focus on the spinal cord | |
| JP2012041342A5 (enExample) | ||
| Lozano et al. | Nanomedicine for the cardiac myocyte: where are we? | |
| Galipeau | Mesenchymal stromal cells for graft-versus-host disease: a trilogy | |
| JP2011528333A5 (enExample) | ||
| JP2010528008A5 (enExample) | ||
| JP2017522288A5 (enExample) | ||
| Santhanam et al. | Cardiovascular effects of erythropoietin: an update | |
| Goodwin et al. | From bench to bedside and back: improving diagnosis and treatment of craniofacial malformations utilizing animal models | |
| Rasputina et al. | Life quality parameters in patients with combination of stable ischemic heart disease and chronic obstructive pulmonary disease | |
| Zagorulko et al. | Integrative methods of diagnosis and treatment of the chronical pain | |
| Nastashenko | Clinical aspects of external postoperative biliary fistulas diagnostics | |
| Otamuradov | Rectovestibular fistula with normal anus | |
| ZENG et al. | THE CLINICAL VALUE OF ACCELERATED RECOVERY CARE IN PULMONARY REHABILITATION OF PERIOPERATIVE LUNG CANCER PATIENTS | |
| Li et al. | B A multi-OMICS approach to generate novel mechanistic insights and new targets for cardiovascular regeneration in the ischaemic adult heart | |
| Bykov et al. | Syndrome-pathogenetic Postoperational Rehabilitation of Patients with Dishormonal Mastopathy | |
| Бiловол et al. | COMPARATIVE ANALYSIS OF USING VARIOUS SCHEMES OF TREATMENT OF PATIENTS WITH POSTINFARCTION CARDIOSCLEROSIS AND TYPE 2 DIABETES | |
| Wang | AB087. The biotherapy for bladder cancer | |
| Vacheva | REHABILITATION PROGRAM IN PATIENTS WITH ALGODYSTROPHY AFTER DISTAL RADIUS FRACTURE | |
| Dogolich | BIOFLAVONOID QUERCETIN AS AN AGENT TO OPTIMIZE A COMPLEX THERAPY OF PATIENTS WITH GOUT HAVING A HIGH RISK OF COMORBIDITY AND VASCULAR RISK | |
| Anfilova | Risk factors for vascular endothelial damage in chronic urogenital chlamydiosis and ways of their correction | |
| Goncharov | The value of therapeutic physical culture in the treatment of large joints osteoarthritis | |
| МҰҚАНОВ et al. | IMPROVING THE DIAGNOSIS AND SURGICAL TREATMENT OF THORACOABDOMINAL WOUNDED | |
| Agius et al. | Do bipolar II and bipolar I disorder have different genotypes and why do we observe unipolar depression converting to bipolar II and then bipolar I? | |
| Díaz et al. | Mental health and drug |